1
CURRICULUM VITAE
Rodney John Baber
MB.BS, B.Pharm., FRCOG, FRANZCOG
Clinical and Academic appointments.
2004 -
Clinical Associate Professor of Obstetrics and Gynaecology
Sydney Medical School, The University of Sydney
1995 – 2004
Clinical Senior Lecturer in O&G, The University of Sydney
1989 – 2004
Clinical Lecturer in O & G, The University of Sydney
1989 -
Visiting Obstetrician & Gynaecologist, Royal North Shore
Hospital , North Shore Private and Mater Hospitals, Sydney
1988 - 1989
Senior registrar in O & G Kings College Hospital London
Research Fellow in Reproductive Endocrinology, The
Lister Hospital, London
1986 - 1988
Senior Professorial registrar in O & G, RNSH
1985 - 1986
Registrar in O & G Odstock Hosp. Salisbury, Wiltshire, UK
1984 - 1985
Registrar in Obstetrics & Gynaecology, RNSH
Other appointments.
2011-2014
General Secretary and President elect, International
Menopause Society
2011-
Chair. Clinical Advisory Board, Family Planning
Association of NSW
2011-
Member, RANZCOG Education and Assessment
Committee
2011-2013
Chair, Medical Advisory Council, NSPH, Sydney
2013-
Deputy Chair, MAC, North Shore Private Hospital
2010 -
Associate Editor ANZ J Obstetrics and Gynaecology
2008 - 2011
General Secretary Elect International Menopause Society
2008 -
Board Member, International Menopause Society
2008 - 2011
Chair, Division of Obstetrics, Gynaecology and Neonatal
paediatrics, North Shore Private Hospital
2008 - 2011
Member Medical Advisory Council, NSPH, Sydney
2
2008 -
Member Patient Care Review Committee, North Shore
Private Hospital, Sydney
2004 - 2010
Chair, Scientific Programme Organising Committee, Asia
Pacific menopause Federation Congress. Sydney 2010
2007 - 2009
Member, Editorial Board, Clinical Updates in Breast Cancer
2007 -
Member, Editorial Board, Climacteric, The Journal of
The International menopause Society
2004 - 2008
Chair, Scientific Programme Organising Committee,
Australasian Menopause Society
2004 - 2006
Immediate Past President Australasian Menopause Society
member Education Sub Committee, AMS
2001- -2004
President, Australasian Menopause Society
2001 -
Member, Curriculum Advisory Committee, Master of
Medicine ( Reproductive Endocrinology) Course
Sydney medical school, The University of Sydney
1999 – 2001
President Elect, Australasian Menopause Society
1999 – 2004
Treasurer, NSW State Committee RANZCOG
1997 – 1999
Member, NSW State Committee, RANZCOG
1997 – 1999
Chair NSW State Reference Committee, a joint
committee of RANZCOG and RACGP
1997 - 2001
Vice President, Australasian Menopause Society
1993 – 1996
Treasurer, Organising Committee, 8th International Congress
on the Menopause, Sydney, 3-8 Nov, 1996
1992 – 1997
Treasurer, Australasian Menopause Society
1989 – 2007
Committee Member, Australasian Menopause Society
1989 -
Reviewer, Medical Journal of Australia, Fertility and
Sterility, Climacteric, Maturitas, Expert review of
Endocrinology and Metabolism, Australian & New
Zealand Journal of Obstetrics and Gynaecology, JCEM,
Medicine Today
Clinical leadership
In 1990 I established and continue to head the Menopause Clinic at Royal
North Shore Hospital.
This is the only unit involved in research into the menopause which is
affiliated to The University of Sydney.
The clinic is now a recognized centre for national and international Phase II
and Phase III trials related to the menopause
The clinic has developed a national and international reputation for clinical
3
management, research projects, original research, and teaching and ongoing
education, enhancing the profile of both Royal North Shore Hospital and The
University of Sydney. The clinic roles include clinical service, teaching of
research fellows, registrars and medical students plus research.
Active involvement in the Royal North Shore Hospital Quality Assurance
programme, involving regular attendance at and participation in monthly
review meetings as well as rostered role as case reviewer and discussant.
Member of The Patient Care Review Committee at North Shore Private
Hospital charged with monitoring clinical standards and patient care
Chairman of Medical Advisory Committee, North Shore Private Hospital
Member of The Education and Assessment sub committee of RANZCOG
Active involvement in the Continuing Education Programme of The Royal
Australian and New Zealand College of Obstetrics and Gynaecology.
Most recent Accreditation issued in 2012 and valid for 3 years.
Key opinion leader in the area of post menopausal women’s health, regularly
providing information and advice to The Royal Australian and New Zealand
College of Obstetrician and Gynaecologists, The Royal Australasian College
of General Practice, Regional Medical Societies The Pharmaceutical Society
and the Media.
Principal researcher at the menopause clinic, RNSH
Since the inception of the menopause clinic in 1990 funds raised for research
amount to over $ 1,500,000.00 .
Our ongoing research programme involves 4 consultants, one clinical nurse
specialist plus research fellows of whom eleven have progressed through our
clinic and research programme thus far including
Dr Kaye MacKinnon
Dr Moya Molloy
Dr Rod Kirsop
Dr Clare Templeman
Dr Devora Lieberman
Dr Robert Lahoud
Dr Shan Visvalingam
Dr Tom O’Gorman
Dr Corinne Patching
Dr Catriona Rowntree
Dr Natasha Andreadis
Dr Sonal Karal
Dr Manny Mangat
Recent areas of research:
A Randomised, double blind placebo controlled trial of the effect of an
Australian developed and patented supplement of clover isoflavones
(phyto-estrogens) on markers of bone turnover, bone mineral density, serum
lipids and breast mammography. This is a Phase III trial of international
significance being conducted in conjunction with the Dept. of endocrinology,
RNSH, ( P Clifton Bligh and G Fulcher ) preliminary data has already been
4
presented at international meetings in The United States and Europe
A doubleblind randomised placebo controlled trial of the effects of
Conjugated equine estrogens plus bazedoxifene on endometrial safety
A double blind randomized placebo controlled trial of the Effects of
Basedoxifene ( a third generation selective estrogen receptor modulator )
on BMD and fracture incidence in post menopausal osteoporotic women.
A multi centre International multi centre Phase II trial currently ongoing.
A double blind randomized placebo controlled trial to investigate the safety
and efficacy of Tibolone in post menopausal symptomatic women with a
personal history of breast cancer in the past 5 years. Now concluded.
Teaching Experience
Active member of the teaching staff of the University of Sydney
Department of Ob/Gyn. at RNSH in the GMP since appointment as a clinical
lecturer in 1990.
Teaching includes one on one teaching with patients in the menopause clinic as
well as formal lectures and problem based learning sessions
Lecturer in the Master of Medicine in Reproductive Health post graduate course
conducted by The Department of Obstetrics and Gynaecology at The University
of Sydney.
This involves lectures on Hormones and Cancer as well as the physiology,
pathophysiology and treatment of the menopause including management of
osteoporosis, heart disease, urogenital complaints and symptoms.
Member of the curriculum advisory committee for the Master of Medicine
In Reproductive Health at The University of Sydney.
Supervisor and teacher of medical registrars training in Obstetrics and
Gynaecology and Endocrinology at Royal North Shore Hospital and North Shore
Private Hospital including formal registrar training sessions, informal group
sessions and supervision in the delivery suite, operating rooms and clinics.
Other post graduate teaching involvement including viva voce training for
registrars preparing for their Part II examinations and formal lectures at
RANZCOG Post Graduate Obstetric and Gynaecology training courses.
Regular involvement in formal teaching sessions for candidates preparing for
The Diploma in Obstetrics and Fellowship of The Royal Australian and New
Zealand College of Obstetricians and Gynaecologists.
Invited Lecturer to Family Medicine Programme of The Royal Australasian
College of General Practitioners.
Invited lecturer at Australian Medical Association Scientific meetings
Invited lecturer at meetings and workshops for FPA Health.
Invited speaker at Continuing Education Meetings for The Pharmaceutical
Society
5
Invited lecturer in the Master of Pharmacy post graduate course, University of
Sydney
Invited lecturer at many workshops, small group discussions and dinner meetings
on aspects of the menopause convened by The Australasian Menopause Society,
Regional medical societies and by pharmaceutical companies.
Invitee to write guidelines for the use of post menopausal hormone Therapy for The
Royal Australian and New Zealand College of Obstetricians and Gynaecologists
Invited lecturer to various international meetings
These include:
The Royal Society of Medicine, London, UK
The Phillipines Menopause Society, Manila, Phillipines
The Thai College of Obstetrics and gynaecology, Bangkok, Thailand
The North American Menopause Society, San Francisco and New York, USA
The Taiwan Obstetric and Gynaecology Society, Taipei, Taiwan
The Malaysian Obstetric and Gynaecology Society, Kuala Lumpur,
Genting and Kota Kinabalu, Malaysia
The Knopp Research Foundation and Chilean Menopause Society, Santiago,
Chile
The European Menopause Experts meeting, Malta, as Chair and speaker
The Asia Pacific Menopause Federation Scientific meeting, Pattaya, Thailand
Keynote opening address and invited speaker
The Shanghai Obstetric and Gynaecology Society, Shanghai, China
The Hong Kong Menopause Society, Hong Kong
The Australian Medical Association Offshore meeting, Lisbon Portugal
The Singapore Menopause Research Society, Singapore
The Indian Obstetrics and Gynaecology Scientific meeting, Agra, India
Controversies in Obstetrics and Gynaecology meeting, Bangkok Thailand
Korean Obstetric & Gynaecology Scientific Meeting, Jeju, and Seoul Korea
Singapore Menopause Congress, Singapore
The Australian Medical Association off shore meeting, Sicily,Italy
The Australasian Menopause Society ASM Wellington NZ
Annual Scientific meetings RANZCOG Perth WA, Brisbane, Qld
The Malaysian Menopause Society Scientific Meeting Kuala Lumpur
The European Society of Gynaecology Meeting Rome
FIGO Capetown
The Australasian Menopause Society Meeting Canberra
The Taiwan Menopause Society, Taiwan
The Malaysian Menopause Society Scientific Congress Malaysia 2011
Hong Kong O&G Society Meeting Hong Kong 2011
International Menopause Society triennial Congress Rome 2011
Australasian Menopause Society ASM Brisbane 2011
The Endocrine Society of Australia Melbourne 2012
HRT Consensus Meeting for IMS Paris 2012
The South African Menopause Society Cape Town 2013
The Malaysian Menopause Society Kuala Lumpur 2013
The China Menopause Society 2013
The Asia Pacific Menopause Federation Tokyo 2013
Joint IMS/ Indian Menopause Society Meeting Mumbai 2013
Details are listed below.
6
Current teaching commitment to faculty of medicine:
Clinical teaching of medical students for 1 morning per week .
1 formal lecture per term to GMP students in Obstetrics and Gynaecology
Problem based learning teaching to students in the GMP
Teaching of medical students and registrars during weekly operating lists
Teaching of post graduate students in The Master of Medicine in Reproductive
Health course conducted by The University of Sydney .
Research / Scholarship
Peer Reviewed Grant:
1999 Australasian Menopause Society $32,000.00
Baber R Hansen R Visvalingam S
Changes in total body composition in post menopausal women following treatment
With subcutaneous estradiol implants
Non peer reviewed grants: 26 totalling approx. $1,100,000
AWARDS AND HONOURS
2006 Medical Media Award for outstanding service to the media and the
community. Press Council of Australia
2007 Australasian menopause Society Distinguished Service Award
2012 RANZCOG Distinguished Service medal
Major completed studies
In 1988-89 I was involved in the establishment of one of the first oocyte donation
clinics for the treatment of prematurely menopausal women in The United
Kingdom a number of significant publications and innovations in patient care
and treatment arose from this initiative.
During this time I was also involved in research work at The Lister Fertility and
endocrinology centre in London where we conducted original research into the
effects of subcutaneous estradiol and testosterone implants on menopausal
symptoms, bone density and the pre menstrual syndrome.
Between 1990 -1995 I was a principal investigator and responsible for the second
largest number of enrollments in the first major phase III trial conducted in
Australia to examine the effects of a combined continuous regimen of post
menopausal hormone therapy on bone density, lipids, menopausal symptoms and
quality of life.
Several papers published in peer reviewed journals arose from this work and the
published findings have significantly affected Australian clinical practice.
Between 1992-1994 I was a principal investigator in a similar randomized double
blind placebo controlled trial examining the effects of a regimen of con jugated
estrogens and progestins on bone density and serum lipids in post menopausal
Australian women
7
In the mid 1990s we were the first Australian centre to participate in Phase II
randomized clinical trials of the safety and efficacy of transdermal patches
containing estrogen and progestin for the treatment of menopausal symptoms.
In 1998 I conducted the first Australian trial examining the effects of long term
estradiol implants on menopausal symptoms and biochemical markers of wellbeing as well as the phenomenon known as tachyphylaxis. Our published findings
have been utilized in Australian guidelines on current best practice in the use of
implants and other forms of hormone replacement therapy
In 1999 I conducted the first Australian randomized cross over trial of the effects
of a dietary supplement of red clover phytoestrogens on menopausal symptoms in
post menopausal women. The findings of this trial are still often referred to by
other researchers and as a guide to clinical practice
MEMBERSHIP OF
LEARNED SOCIETIES
The Fertility Society of Australia
The Australasian Menopause Society
The Australian Gynaecological Endoscopy Society
The International Menopause Society
The North American Menopause Society
The Royal Society of Medicine
Publications
Books
The Active Management of Infertility.
Abdalla H and Baber R.
In: Studd J. (ed)
Progress in Obstetrics and Gynaecology Vol. 8 p.273-289 Churchill Livingstone.
London
The Premature Menopause.
Baber R, Abdalla H and Studd J.
In: Studd J (ed)
Progress in Obstetrics and Gynaecology Vol 9. p.209-226 Churchill Livingstone
London
The Menopause
Baber R and Studd J.
In: Shaw R, Soutter P and Stanton S(eds).
Gynaecology 1992 341-355
Churchill Livingstone. London
Ovarian Replacement Therapy
B Stuckey and R Baber
In: Therapeutic Guidelines Endocrinology
2nd edition 2001; 117-128
Therapeutic Guidelines Ltd, Melbourne Victoria
8
The role of Isoflavones in Health
R Baber
In: Phytoestrogens in Health and Disease
Royal College of Chemistry,
London 2012
HRT and Breast Cancer
R Baber
In: Studd J (ed)
Progress in Obstetrics and Gynaecology 2013
Publications in Peer Reviewed Journals
Midazolam as an intravenous induction agent for general anaesthesia; a clinical trial
Baber R, Hobbes A, Munro I, Purcell G and Binsted R.
Anaesth. Intensive care 1982 1: 29-35
The impact of an instant pregnancy test kit on the operations of a hospital casualty
Baber R, Bonifacio M, Saunders D.
Aust. NZ J Obstet Gynaecol. 1988 28: 134-136
Assessment of the blood flow to the corpus luteum in IVF patients using transvaginal
doppler ultrasound.
Baber R, McSweeney M, Porter R, Picker R, Warren P, Kossoff G and Saunders D.
Clin Reprod. Fertil. 1987 5: 300-301
TVOPU in an IVF programme; our first 600 cases.
Porter R, Baber R, Picker R, Robertson R, Dawson E and Saunders D.
Clin Reprod. Fertil. 1987 5: 302-303
Transvaginal ultrasound directed oocyte collection in an IVF programme; successes
and complications.
Baber R, Porter R, Picker R, Robertson R, Dawson E and Saunders D.
U Ultrasound Med 1988 7: 377-379
Transvaginal doppler assessment of the female pelvis in early pregnancy.
McSweeney M, Baber R, Porter R, Picker R, Warren P, Gill R, Kossoff G
and Saunders D.
Clin Reprod. Fertil. 1987 5: 301-302
The outcome of pregnancies achieved within three months of an unsuccessful IVF
treatment cycle.
Lee S, O'Neil M, Baber R and Saunders D.
Clin Reprod. Fertil. 1987 5: 280-281
Transvaginal pulsed doppler assessment of the blood flow to the corpus luteum in IVF
patients following embryo transfer
Baber R, McSweeney M, Gill R, Porter R, Picker R, Warren P, Kossoff G
and Saunders D.
Br J Obstet. Gynaecol. 1988 95: 1226-1230
In Vitro Fertilisation
Abdalla H, Leonard T, Baber R, Kirkland A, Stocker P, Owen E and
Studd J.
Br Med J. 1988 296: 1470(ltr)
9
Early pregnancy support in an IVF programme. Does human chorionic
Gonadotrophin reduce the miscarriage rate?
Baber R, Kuan R, Porter R and Saunders D.
Asia Oceania J Obstet. Gynaecol. 1988 14: 433-435
Calcitonin for post menopausal bone loss.
Studd J and Baber R.
Lancet 1988 1(8597): 1277-1278
An alternative regimen of hormone replacement therapy to improve compliance.
Kemp J, Fryer J and Baber R.
Aust. NZ J Obstet. Gynaecol. 1989 28: 66-69
Hormone replacement therapy and Cancer.
Baber R and Studd J.
Br J Hospital Med. 1989 41: 142-149
Pregnancy following premature ovarian failure using tubal and intra uterine transfer
of cryopreserved zygotes.
Abdalla H, Baber R, Kirkland A, Leonard T and Studd J.
Br J Obstet. Gynaecol. 1989 96: 1071-1075
A comparison of the attitudes and opinions of volunteer donors and infertile patient
donors on an ovum donation programme.
Power M, Baber R, Kirkland A, Leonard T, Abdalla H, Studd J.
Human Reproduction 1990 5: 352-355
Ovum Donation
Baber R and Abdalla H.
Br J Hospital Med 1989 (42) 442-450
Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral
Norethisterone in a placebo controlled cross over study.
Watson N, Studd J, Savvas M and Baber R.
Lancet 1989 8665: 730-732
Timed oocyte collection in an assisted conception programme using GNRH analogue.
Abdalla H, Baber R, Leonard T, Kirkland A, Power M, Mitchell A and Studd J.
Human Reproduction 1989 4: 927-930
The long term effects of oestradiol implant therapy for the treatment of
the premenstrual syndrome.
Watson N, Studd, Baber R and Savvas M.
Gynecol Endocrinol. 1990 4(2) 99-107
The relationship between plasma oestradiol and the increase in bone density in post
menopausal women after treatment with subcutaneous hormone implants.
Studd J, Savvas M, Fogelman I, Baber R and Watson N.
Am J Obstet Gynecol. 1990 163: 1474-79
A report on 100 cycles of ovum donation: factors affecting the outcome.
Abdalla H, Baber R, Kirkland A, Leonard T, Power M, Studd J.
Human Reproduction 1990 5(8): 1018-22
The detection of anti-ovarian antibodies by indirect immunofluorescence in patients
with premature ovarian failure.
Kirsop R, Brock T, Robinson B and Baber R.
Reproduction, Fertility and Development 1991 3(5) 537-541
10
Effects of oral contraceptives containing oestrogen combined with Norethisterone or
Levonorgestrel on erythrocyte cation transport in normal women
Stokes G, Monaghan J, Flemming C, Johnston H, Jones M, Pinkerton G and Baber R.
Clinical Science (1992) 82: 505-512
Comparison of attitudes of donors and recipients to oocyte donation.
Kirkland A, Power M, Burton G, Baber R, Studd J & Abdalla J.
Human Reproduction 1992 7(3): 355-357
Hormone replacement therapy and breast cancer.
Baber R, and Kemp J.
Med. J. Aust. 1993 158; 722
Quintuplet pregnancy after Clomiphene with successful outcome.
Roach V, Baber R, Saunders D and Arnold J.
ANZ J Obstet Gynaecol. 1994 34: 53-55
In Vitro Studies of Endometrial Biochemistry.
Sinosich M, Zakher A, Baber R, Torode H, Saunders D.
Cell Biology International 1994, 18(12):1129-1138
Modern HRT Regimens
Baber R.
Current Therapeutics 1995, February; 45-49
A Guide to the Selection of HRT.
Baber, R.
Current Therapeutics 1997, Vol 38; 1 P24
Bleeding Patterns and Endometrial Histology on Continuous Combined
Hormone Replacement Therapy
Nand S, Webster M, Baber R, O Connor V
Obstet Gynecol 1998 91;5(1) P678-685
An audit of Oestrogen Implant Hormone Replacement Therapy
Templeman C, Baber R, Moreton T, Hansen R and Quinn D.
Aust NZ J. Obstet Gynaecol 1998; 38;3:455-460
Responsibilities of Referees (letter)
Baber R & Farrell E
Climacteric 1998; 1:166
Menopausal symptom control and side effects on continuous estrone sulphate
and three doses of medroxyprogesterone acetate.
Nand S, Webster M, Baber R and Heller G
Climacteric 1998;1: 211-218
A Randomised Placebo Controlled Trial of an Isoflavone Supplement and
Menopausal Symptoms in Women
Baber R, Templeman C, Moreton T, Kelly G & West L
Climacteric 1999 ; 2: 1-8
Bone density effects of continuous estrone sulfate and varying doses
of medroxyprogesterone acetate.
Nand S, Wren B, Gross B, Heller G, Webster M, Baber R.
Obstet Gynecol 1999; 93: 1009-1013
11
The Effect of an isoflavone dietary supplement on serum
Lipids, forearm bone density and endometrial thickness
In Post Menopausal Women.
Baber R, Clifton Bligh P, Fulcher G, Lieberman D, Nery L
and Moreton T
Menopause 1999; 6(4): 326
The role of oestrogen in cardiovascular disease: benefit or harm?
MacLennan A and Baber R
Medical Journal of Australia 2000; 172 (7): 347
The Effect of Isoflavones extracted from Red Clover on Lipid and Bone metabolism
Clifton-Bligh P, Baber R, Fulcher G, Nery M-L, Moreton T
Menopause 2001 Vol.8, No4, 259-265
Hormone Replacement Therapy and The Breast
MacLennan A, Lawton B, Baber R
BMJ 2002; 324: 915 (letter)
For Debate: HRT or Not
Baber R, O’Hara J Boyle F
MJA 2003; 178: 630-633
HRT: to use or not to use?
Baber R, O’Hara J, Boyle F
MJA 2003; 179: 392 (letter)
The Role of HRT and SERMs after The Womens Health Initiative.
Baber R
Malaysian J Obstet Gynaecol. 2003 Vol 8 No 4 Suppl, 15-17
Effects of 20mg oestradiol implant therapy on bone mineral density, fat distribution
and muscle mass in postmenopausal women.
Hansen R, Raja C, Baber R, Lieberman D, Allen B
Acta Diabetol (2003) 40:S191-S195
Transition to raloxifene with and without low dose estrogen therapy in post
Menopausal women: effects on serum lipids and fibrinogen – a pilot study
O’Neill S, Eden J, Baber R, Ekangaki A, Stocks J Wolthers T and Davis S
Climacteric 2003;6: 347-353
Transition from estrogen therapy to raloxifene in post menopausal women:
effects on treatment satisfaction and the endometrium: a pilot study
Davis S, O’Neill S, Eden J, Baber R, Ekangaki A, Stocks J and Thiebaud D
Menopause 2004; 11 (2): 167-176
Hip Girth as a predictor of abdominal adiposity in post menopausal women
Raja C, Hansen R Baber R Allen B
Nutrition 2004, 20;9:272-277
The Fertility and menopause related needs of younger women with a diagnosis of
Breast Cancer.
Thewes B,Meiser B Taylor A, Phillips K Pendelbury S, Capp A, Dalley D Baber R
J Clin Oncol 2005;23: 5155-65
12
Effects of low dose hormone therapy on menopausal symptoms: a review of
Randomized Clinical trials
Peeyananjarassri K & Baber R
Climacteric 2005;8: 13-23
Therapy for menopausal symptoms during and after treatment for breast cancer
Baber R Hickey M & Kwik M
Drug Safety 2005;28: 1085-1100
Complementary and hormonal therapy for vasomotor symptom relief: a conservative
Approach
Nachtigall L, Baber R, Barentsen R, Durand N, Panay N et al
J Obstet Gynaecol Can. 2006;28: 279-289
Premature Ovarian Failure: A Review
Nippita T and Baber R
Climacteric 2007;10:11-22
HRT for the older woman
Baber R
O & G. 2007 April
HRT and Gynaecological cancers
Baber R
Menopausal Medicine 2007; 14:S8-12
A Randomised Placebo Controlled Trial on the effectiveness of a herbal formula to
Alleviate Vasomotor menopausal symptoms
van der Sluijs C, Bensousson A, Chang S and Baber R
Menopause 2009; 16(2): 336-44
Safety and efficacy of tibolone in breast cancer patients with vasomotor symptoms; a
double blind, randomized, non inferiority trial.
Kenemans P et al for The Liberate Study Group
Lancet Oncology 2009;10:135-46
Vernix caseosa peritonitis; no longer innocent or rare
Stewart O, Morris A, Baber R
International Journal of Case Reports 2009;10:3:60
Hormone therapy use and risk of ovarian cancer
MacLennan A and Baber R
JAMA 2009; 302 (20):2203 (letter)
Phytoestrogens and post reproductive health
Baber R
Maturitas 2010;66: 344-49
Updated Clinical recommendations for the use of Tibolone in Asian women
Huang K E and Baber R J
Climacteric 2010 ;13: 317-27
Recommendations for the management of post menopausal vaginal atrophy
Sturdee D and Panay N for the IMS Writing Group
Climacteric 2010;3:509-522
13
Breast Cancer in Post menopausal women after hormone therapy.
Baber R. JAMA 2011;305: 466 (ltr)
Updated IMS Recommendations for the use of
Hormone replacement therapy. Sturdee D, Pines A, Baber R et al
Climacteric 2011;14:302-320
Menopausal Hot Flushes and Night sweats; where are we now?
Archer D, Sturdee D, Baber R et al. Climacteric 2011;00:1-14
Whats new in the management of heavy menstrual bleeding
Baber R
Medicine Today 2011;12:
Multiple Choice in the management of the menopause
Maclennan A, Morris D (Baber R Panel member)
Climacteric 2011;14:697-702
Sustained efficacy and safety of bazedoxifene in preventing fractures in post
menopausal women with osteoporosis: results of a 5 year randomized placebo
controlled study. Silverman S, Chines A, Kendler D, Baber R et al Osteoporosis Int
2012;23:351-63
Editor retires to 19th Hole. Yours Aye, Alastair
Baber R and Burger H
Climacteric 2012
Possible nett harms of breast cancer screening
Baber R Climacteric 2012;15:398-9
Menopausal symptoms in breast cancer survivors
Cusack L, Brennan M, Baber R, Boyle F
Br J Gen Pract 2013;63:51-2
Updated 2013 IMS recommendations on MHT and preventive strategies for midlife
Health.
De Villiers T, Pines A, Panay N, Gambacciani M, Archer D, Baber R et al
Climacteric 2013;16:316-37
Oncology in midlife and beyond
Gompel A, Baber R, de Villiers T et al
Climacteric 2013;
East is east and West is west. Perspectives on menopause in Asia nd the West
Baber R
Climacteric 2013
Presentations at Scientific Meetings
The impact of an instant pregnancy test kit on the operations of a hospital
casualty department.
4th Australian Congress of Obstetrics and Gynaecology. Perth WA 1987
Transvaginal doppler assessment of the blood flow to the corpus luteum in
infertile patients.
Australian Society for Ultrasound in Medicine Annual Scientific Meeting.
Canberra ACT 1987
14
Transvaginal oocyte pickup in an IVF programme; our total experience.
4th Australian Congress of Obstetrics and Gynaecology. Perth WA 1987
Assessment of the blood flow to the corpus luteum in IVF patients using
transvaginal doppler ultrasound.
Fertility Society of Australia, Annual Scientific Meeting. Sydney NSW 1987
Transvaginal doppler assessment of blood flow to the ovaries
in infertile patients.
American Roentgen Ray Society Annual Meeting. San Francisco, California 1988
Improved pregnancy rates and clinical efficiency in an IVF/GIFT programme
using LHRH analogue.
European Society of Human Reproduction and Embryology Annual Meeting.
Barcelona 1988
Frozen zygote intra fallopian transfer for oocyte donation.
ESHRE Annual Meeting. Barcelona 1987
Rapid increase in bone mass with subcutaneous oestradiol and testosterone implants.
FIGO World Congress. Rio de Janeiro 1988
Transvaginal doppler assessment of pelvic vascularity in early pregnancy.
International Perinatal Doppler Society Annual Meeting. Kansas, USA 1988
LHRH Analogue for poor responders in an IVF programme.
Fertility Society of Australia Annual Meeting. Newcastle 1988
Greater success and improved efficiency in an IVF programme with the
mandatory use of LHRH analogue.
FIGO World Congress. Rio de Janeiro 1988
Delayed oocyte collection with LHRH analogue on an assisted conception
programme.
British Fertility Society Annual Meeting. London 1988
High pregnancy rates following transfer of frozen thawed zygotes on an ovum
donation programme.
VI World Congress of In Vitro Fertilisation and alternate assisted conception.
Jerusalem 1989
Attitudes towards egg donation of volunteer donors on an ovum donation programme.
VI World Congress of IVF and alternate assisted conception. Jerusalem 1989
Improved cost effectiveness and treatment outcome on an assisted conception
programme with the use of LHRH analogue.
ESHRE Annual Meeting. Malmo, Sweden 1989
Pregnancies following tubal and intra-uterine transfer of frozen thawed zygotes
on an ovum donation programme.
British Congress of Obstetrics and Gynaecology. London 1989
The skeletal effects of long term subcutaneous oestrogens in post menopausal women.
British Congress of Obstetrics and Gynaecology. London 1989
15
A placebo controlled study of an anovulatory dose of oestradiol patches and cyclical
oral Norethisterone in the treatment of the premenstrual syndrome.
British Congress of Obstetrics and Gynaecology. London 1989
The treatment of the premenstrual syndrome by suppression of ovulation
with transdermal oestradiol patches.
British Congress of Obstetrics and Gynaecology. London 1989
Increase in vertebral bone density following one year of hormonal implant therapy
in women who have previously received oral hormone replacement therapy.
British Congress of Obstetrics and Gynaecology. London 1989
The prevention of bone loss in menstruating perimenopausal women using
subcutaneous oestrogen and testosterone implants.
5th Australian Congress of Obstetrics and Gynaecology. Brisbane 1989
The prognostic value of the number of oocytes collected and the in vitro fertilisation
rate of extra oocytes in a GIFT cycle.
5th Australian Congress of Obstetrics and Gynaecology. Brisbane 1989
The treatment of the premenstrual syndrome using transdermal oestradiol patches
and cyclical oral Norethisterone.
5th Australian Congress of Obstetrics and Gynaecology. Brisbane 1989
Substantial increase in bone density in post menopausal women following treatment
with subcutaneous oestradiol and testosterone implants.
5th Australian Congress of Obstetrics and Gynaecology. Brisbane 1989
Development of an endometrial explant model for the investigation of
uterine receptivity for implantation.
Fertility Society of Australia Annual Meeting. Perth 1990
The auto immunological status of patients requiring donor oocytes
on an IVF programme.
1st International Scientific Meeting of the RCOG. Singapore 1990
Predictors of post menopausal bone loss and the effect of HRT on
post menopausal bone density.
6th International Congress on the Menopause. Bangkok 1990
Comparison of attitudes of volunteer donors and recipients to oocyte donation.
ESHRE Annual Meeting. Milan 1990
A comparison of the attitudes of donors and recipients on an ovum donation
programme.
British Fertility Society Annual Meeting. Leeds December 1990
The psychosocial impact of a premature menopause.
Australian Menopause Society Meeting. Adelaide 1991
The detection of anti-ovarian antibodies in patients with premature ovarian failure
using indirect immuno-fluorescence.
Australian Menopause Society Meeting. Adelaide 1991
The safety and efficacy of long cycle hormone replacement therapy.
7th International Congress on the Menopause. Stockholm, Sweden June 1993
16
A survey of the attitudes of Australian general practitioners to recommending
hormone replacement therapy.
7th International Congress on the Menopause. Stockholm, Sweden June 1993
Weight gain and HRT: An educational approach to patient concerns.
8th International Congress on The Menopause, Sydney 1996
Efficacy of Ogen Provera Regimens
8th International Congress on The Menopause, Sydney 1996
A Survey of patients attitudes towards attending a menopause clinic
8th International Congress on The Menopause, Sydney 1997
Compliance with HRT in women attending a menopause clinic
8th International Congress on The Menopause, Sydney 1997
A study of clover extract as a treatment of menopausal symptoms
1st Australasian Menopause Society Congress, Perth 1997
The effect of a dietary supplement of isoflavones (P-081) on Serum lipids
and bone density in post menopausal women
Annual Scientific Meeting, North American Menopause Society, New York, 1999
The impact on uterine bleeding, body mass and estradiol levels in patients using
estradiol implants compared to matched controls
RANZCOG NSW-Qld Meeting Noosa, Qld 2000
The association between estradiol levels, obesity and uterine bleeding in post
menopausal women using estradiol implant therapy compared to matched controls
Australasian menopause Society Annual Scientific Meeting, Adelaide, S.A. 2000
The effect on body weight and body composition of estradiol implants in post
menopausal women compared to matched controls
Australasian menopause Society Annual Scientific Meeting, Adelaide, S.A. 2000
The effect of menopause related quality of life on body image, eating and exercise
Australasian menopause Society Annual Scientific meeting Brisbane Qld 2011
Invited Lectures
Ovum donation for the premature menopause
Gynaecological Endocrinology Seminar. The Royal Society of Medicine.
London 1989
The Modern Management of the Menopause.
44th Annual Convention, Philippines Obstetrics and Gynaecology Society.
Manila 1990
Feminine Forever; HRT Risks and Benefits.
RNSH Annual Clinical Meeting. 1990
The Medical Management of the Menopause.
Usyd Fac Med Internal Medicine Seminar. Sydney 1992
17
Non oral Hormone Replacement Therapy
47th Annual Congress Phillipines O & G Society, Manila 1994
Continuous combined HRT
Annual Scientific Meeting Royal Thai O & G Society, Bangkok October 1995
How to evaluate post menopausal bleeding and monitor endometrial health A workshop
North American Menopause Society 6th Annual Meeting, San Francisco 1995
Safety and Efficacy of Continuous Combined Hormone Replacement therapy
Annual General Meeting Taiwan Menopause Society, Taiwan 1998
Climacteric Conundrums
Annual Scientific Meeting RACOG / RANZCOG, Adelaide 1998
The Management of the post menopausal woman with a family
History of heart disease.
3rd Annual Scientific Meeting, Australasian Menopause
Society, Cairns 1999
Menopause
University of Sydney Masters in Reproductive Medicine Course
Sydney April 2000
Hormones and Cancer
University of Sydney Masters in Reproductive Medicine Course
Sydney July 2000
The effect of HRT on quality of life in post menopausal women
The Dean’s Lecture
Sydney University, November 2000
Menopause
University of Sydney Masters in Reproductive Medicine Course
Sydney April 2001
Hormones and Cancer
University of Sydney Masters in Reproductive Medicine Course
Sydney July 2001
Do Alternative therapies interfere with Tamoxifen
Royal Australasian College of Surgeons, ASC
Canberra, May 2001
Hormones and Cancer
University of Sydney Masters in Reproductive Medicine Course
Sydney July 2001
Fertility and Hormones after breast cancer
BCAG Young womens’ forum
Sydney, October 2001
The Menopause
RANZCOG Advanced Trainee Course
Sydney, November 2001
18
Low dose Hormone replacement Therapy
University of Queensland Womens Health Conference
Gold Coast, Queensland, February 2002
Complications of HRT
Hormone Update Course
University of NSW
Sydney, February 2002
Menopause
University of Sydney Masters in Reproductive Medicine Course
Sydney April 2002
Hormone Replacement Therapy; Past, Present and Future
Malaysian College of O & G Annual Scientific Meeting
Genting Highlands, Malaysia May 2002
Hormones and Cancer
University of Sydney Masters in Reproductive Medicine Course
Sydney July 2002
The effect of phytoestrogens on menopausal symptoms
Knopp Foundation Scientific Seminar
Santiago, Chile 2002
The effect of phytoestrogens on cardiovascular disease
Knopp Foundation Scientific Seminar
Santiago, Chile 2002
Menopause Update
RANZCOG Advanced Trainee Course
Sydney November 2002
Menopause
University of Sydney Masters in Reproductive Medicine Course
Sydney April 2003
The Role of HRT and SERMs post WHI
Malaysian College of O & G ASM
Kota Kinabalu, Sabah, May 2003
HRT following The Women’s Health Initiative
RANZCOG NSW Queensland Scientific Meeting
Sydney
July 2003
Hormones and Cancer
University of Sydney Masters in Reproductive Medicine Course
Sydney July 2003
The evolution of hormone therapy
Livial Experts Meeting,
Malta, October 2003
Hormones and The Breast
Livial Experts meeting
Malta October 2003
19
Menopause Update
RANZCOG Advanced Trainee Course
Sydney, November 2003
HRT: What have we learned in the past 10 years
Keynote lecture
2nd Asia Pacific Menopause Federation Scientific Meeting
Thailand, March 2004
The effect of Tibolone on the breast
2nd APMF Scientific Meeting
Thailand, March 2004
Hormone Therapy and breast Cancer
Shanghai O&G Society Meeting
Shanghai, China, April 2004
Controversies in HRT and breast cancer
Hong Kong Menopause Society Meeting
Hong Kong April 2004
Menopause
University of Sydney Masters in Reproductive Medicine Course
Sydney April 2004
HRT Update
AMA Annual Offshore Scientific meeting
Lisbon, Portugal May 2004
Phytoestrogens update
AMA Annual Offshore Scientific meeting
Lisbon, Portugal May 2004
The Polycystic ovarian syndrome
AMA Annual Offshore Scientific meeting
Lisbon, Portugal May 2004
Update on Antenatal care
AMA Annual Offshore Scientific Meeting
Lisbon, Portugal May 2004
HRT and Heart Disease
Malaysian O&G Society Annual Scientific Meeting
Kuala Lumpur, Malaysia June 2004
HRT and Breast Cancer
Malaysian O&G Society ASM
Kuala Lumpur, Malaysia June 2004
HRT after The Womens Health Initiative
Singapore menopause research society meeting
Singapore June 2004
HRT and Breast Cancer
Australian HRT Consensus Meeting
RANZCOG, Melbourne, August 2004
20
Menopause Update
RNSH Endocrinology Refresher meeting
RNSH, Sydney, July 2004
Hormones and Cancer
Masters in reproductive medicine course
University of Sydney
August 2004
Phytoestrogens and Bone health
Osteoporosis Seminar
The Garvan Institute
Sydney
August 2004
Non TGA Approved Therapies
Australasian Menopause Society Annual Scientific meeting
Perth, October 2004
HT Current Guidelines
Women’s Health Update
The University of NSW Sydney October 2004
HRT and Heart disease. Is there a role?
RNSH Cardiology Seminar
Sydney
November 2004
Menopause Update
RANZCOG Pre Membership Exam Course
Sydney November 2004
Estrogens, Tibolone and Breast Cancer
Controversies in Obstetrics and Gynaecology
Annual International Meeting
Bangkok, Thailand,
November 2004
Current HT Guidelines
Royal Hospital for Women Annual Hormone Update
The University of NSW, Sydney
February 2005
Clinical effects of Tibolone
Asian Menopause Experts Meeting
Langkawi, Malaysia
April 2005
Hormone therapy: what’s best for the breast?
Korean O&G Society ASM
JeJu Island, Korea
May 2005
Hormones and cancer
University of Sydney
August 2005
21
Polycystic Ovarian Syndrome
AGES Annual Scientific Meeting
Sydney August 2005
Managing menopausal symptoms
Mayne Health Womens’ Health Day
University of NSW
August 2005
Menopause Update
RANZCOG Fellowship Exam Course
Sydney
November 2005
New Data On Hormone replacement therapy
Human Reproductive health through the ages
Adelaide
March 2006
Menopause
University of Sydney M Med Course
Sydney
March 2006
Update on Hormone replacement Therapy
Australian Medical Association Scientific Meeting
Sicily,
April 2006
Non Hormonal therapies for menopausal symptoms
Australian Medical Association Meeting
Sicily
April 2006
New Pap Smear Guidelines
Australian Medical Association scientific meeting
Sicily
April 2006
The Investigation of endometrial bleeding
Australian Medical Association scientific meeting
Sicily
April 2006
HRT Guidelines and Bioidentical HT
Womens Health Update
The University of Queensland
Brisbane
July 2006
A perspective of the risk of breast, ovarian and endometrial cancer
Amongst hormone users
Singapore Menopause Congresss
Singapore
July 2006
22
Choice of HRT Regimens
Singapore Menopause Congress
Singapore
July 2006
Hormones and Cancer
University of Sydney Master of medicine Course
Sydney
August 2006
The Gynaecological Side effects of Hormonal Treatments for breast cancer
Brisbane, Melbourne, Sydney, Adelaide, Perth
October, November 2006
Clinical trials update
Australasian Menopause Society ASM Wellington NZ
September 2006
Managing The Menopause in 2006
RANZCOG
Annual Scientific meeting
Perth
October 2006
HRT What’s new, what’s important
Annual Endocrinology Update, University of NSW Sydney Australia
February 2007
The Menopause
University of Sydney Master of Medicine course
March 2007
HRT and breast cancer
HRT and other gynaecological malignancy
Malaysian Menopause Society ASM Kuala Lumpur Malaysia
April 2007
Hormones and Cancer
University of Sydney Master of Medicine course
June 2007
Menopause Update
Family Planning Association of NSW
Annual GP Update
Sydney June 2007
Clinical Trials Update
Australasian Menopause Society Annual Scientific meeting
Adelaide
September 2007
WHI, WISDOM and LIBERATE
RANZCOG Annual Scientific Meeting
Queensland
October 2007
23
Menopause Update. RANZCOG Fellowship training course
Sydney
October 2007
Workshop on Women and Heart Disease
APMF, Shanghai, China
November 2007
HRT Update. RANZCOG General Practice Update
Sydney
December 2007
Menopause: Physiology and Clinical Aspects
University of Sydney Master of Medicine
Sydney
March 2008
Non hormonal treatments for menopausal vasomotor symptoms
Women’s health Update
Adelaide
May 2008
HRT Update
Hunter Post Graduate Medical Institute Weekend Meeting
Newcastle
August 2008
HRT What’s new
Women’s health and Hormone weekend
The Alfred Hospital / Monash University
Melbourne
November 2008
Menopause Update
Women’s health and Hormone Update
University of NSW
Feb 2009
The Menopause
Masters of medicine post Grad Course
University of Sydney
March 2009
Livial Experts Consensus Group Workshop
Siem Reap, Cambodia
May 2009
Management of CV risk in Obstetric and Gynaecology Practice
HRT Workshop
Hong Kong
July 2009
Barely old enough; managing premature menopause
European Society of Gynaecology
Annual Meeting
Rome, Italy
September 2009
24
Clinical Guidelines for HRT use
Australasian Menopause Society ASM
Canberra, Australia
September 2009
Hormones and Breast Cancer
The IMS Symposium
FIGO, Capetown, South Africa
October 2009
The Menopause
Master of medicine in Reproductive Endocrinology
The University of Sydney
March 2010
Updated Clinical Guidelines for Tibolone
Taiwan Menopause Society Congress
Taipei, Taiwan
May 2010
Managing the menopause in 2010
Taiwan Menopause Society Congress
Taipei, Taiwan
May 2010
Managing Premature Ovarian Failure
Taiwan Menopause Society Congress
Taipei, Taiwan
May 2010
Sex hormones and Cancer
Master of medicine in Reproductive Endocrinology
The University of Sydney
August 2010
HRT using drospirenone
4th APMF Scientific Congress
Sydney, Australia
September 2010
Initiating Hormone therapy near menopause
8th Malaysian College of the menopause annual scientific meeting
Selangor, Malaysia
March 2011
The role of Tibolone in Post menopausal Asian Women
8th Malaysian College of the menopause annual scientific meeting
Selangor Malaysia
March 2011
Long term consequences of Premature ovarian failure
13th World Congress on The Menopause
Rome Italy
June 2011
25
The rationale for developing a new class of contraceptives
Qlaira expert meeting, Hong Kong, July 30-31 2011
Hormones and Cancer
University of Sydney August 2011
The Management of Heavy Menstrual Bleeding
AMS Annual Scientific Meeting
Brisbane September 2011
Cardiovascular and Thromboembolic side effects of Progestins
Australasian Menopause Society Annual Scientific meeting
Brisbane, Qld September 2011
Zoely: A new combination contraceptive containing NOMAC and estradiol.
Specialist Update
Canberra, ACT. October 2011
Update on the menopause
RANZCOG Pre examination Conference
Sydney, NSW. November 2011
Screening mammography: Harm or benefit
Conflicts in Obstetrics and Gynaecology
Bangkok Thailand November 2011
Current advice to women reaching the menopause
Women’s health Conference
Gold Coast Queensland February 2012
Contraceptive Hormones: Recent developments
Women’s Health Conference
Gold Coast Queensland February 2012
Heavy Menstrual Bleeding
Women’s Health Conference
Gold Coast Queensland February 2012
Menopausal women after the MacLennans
Feldshcrift for Prof Alastair MacLennan
Adelaide SA March 2012
HRT use: A systematic review
Advances in Women’s Health Conference
Sydney NSW March 2012
HRT use in difficult circumstances
Endocrine Society of Australia Annual Scientific Congress
Torquay Victoria, April 2012
Managing the Menopause
RANZCOG CREI Course
Sydney, NSW, May 2012
HRT after Breast Cancer
AGES Scientific Congress
Sydney NSW, June 2012
26
Managing the menopause after breast Cancer
Terrigal at The Poche Meeting
Sydney July 2012
Hormones and Cancer
Master of Medicine Post Grad Course
The University of Sydney, August 2012
HRT update 10 years after WHI
Webinar presentation Sydney August 2012
Managing the consequences of early menopause
Australasian menopause Society Annual Scientific Congress
Melbourne Vic. October 2012
Sex hormones and Cancer
Master of Medicine Post grad course, University of Sydney
August 2012
East versus West; is the menopause different
International Menopause Society Workshop
Paris France November 2012
Controversies in Mammographic Screening
South African Menopause Society ASM
Stellenbosch South Africa March 2013
What is the role of Livial
South African Menopause Society ASM
Stellenbosch South Africa March 2013
Mammographic screening; harm or hope
Malaysian Menopause Society ASM Kuala Lumpur
April 2013
Estrogens and SERMS: Implications for the breast
Malaysian Menopause Society ASM
Kuala Lumpur April 2013
Androgen Replacement in Women
Malaysian Menopause Society ASM
Kuala Lumpur April 2013
What is the role of Tibolone in menopausal therapy
Malaysian Menopause Society ASM
Kuala Lumpur April 2013
HRT in Difficult Circumstances
Dept of Endocrinology Clinical Meeting
Royal Prince Alfred Hospital, Sydney
May 2013
The Menopause
Master of Medicine Postgraduate Course
The University of Sydney
June 2013
27
Guidelines for the use of HRT
ASPOG Annual Scientific Congress
Sydney
July 2013
Hormones and Cancer
Master of Medicine post graduate course
The University of Sydney
August 2013
Is there a role for HRT in the 21st Century
FP NSW Annual Scientific Congress
Sydney
August 2013
HRT and Cardiovascular Disease
AMS Annual Scientific Congress
Adelaide
September 2013
HRT in 2013: State of the Art Keynote Lecture
Chinese Menopause Society Annual Scientific Congress
Shijiazhuang, China
September 2013
Mammographic screening: risks and benefits
13th World Congress on Ultrasound in O&G
Sydney
October 2013
Breast Cancer in Asia and The West
Asia Pacific Menopause Federation Annual Scientific Congress
Tokyo, Japan
October 2013
Is there a difference between breast cancer in Asia and The West?
BCGIP Congress
Shanghai, China
November 2013
Phytoestrogens in the treatment of menopausal symptoms
BCGIP Congress
Shanghai, China
November 2013
Long term consequences of Premature Ovarian Failure
ICCIWH Congress
Mumbai, India
December 2013
Benign Breast Disease
ICCIWH Congress
Mumbai, India
December 2013
28